Featured News

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

Researchers found that children initially diagnosed with potential celiac disease had a high risk of developing celiac disease.

Join the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

I am pleased to share a research grant awarded to the Dubcovsky Lab at UC Davis for Development of a Novel Dietary Treatment for Celiac Disease that may significantly reduce the suffering experienced by our patient community.

We are pleased to share the video recording of Dr. Jocelyn Silvester discussing what you need to know about pediatric celiac disease now and in the future.

At UEGW, researchers from Takeda, the University of Sheffield, Columbia University, Coeliac UK, and CDF virtually presented a study entitled, Experiences of a gluten-free diet in patients with celiac disease: a multi-national survey.

Researchers found that roughly one-third of celiac patients reported using probiotics for perceived health benefits, despite the lack of evidence that probiotics are an effective treatment for celiac disease symptoms.

There are more exciting opportunities than ever before to participate in celiac disease clinical trials. Researchers are making groundbreaking progress in the race for better treatments with promising new drug candidates.